Literature DB >> 6824569

In vitro thymidine labelling of human pulmonary neoplasms.

K M Kerr, A M Robertson, D Lamb.   

Abstract

The in vitro thymidine labelling indices (TLI) of 58 human lung tumours were assessed using autoradiography. The labelling technique involved incubation of 1 mm3 tumour fragments with 3H-thymidine (5 muCi ml-1) under conditions of hyperbaric oxygenation at a pressure of 3 atmospheres. Only a rim of labelling was achieved along the edges of fragments and the depth of this rim varied from tumour to tumour. A technique for counting TLIs was therefore devised to take this into account. In general, those tumours showing low TLI values of less than 5.0% showed a greater depth of labelling. The common malignant tumours of the bronchus showed a wide range of values (2.2-30.4%) though the adenocarcinomata had a lower average value than the other groups. With the squamous carcinomata a relationship with differentiation was shown. The mean value for small cell carcinomata (16.9%)--a highly aggressive tumour--was no higher than for the other groups. The low grade malignant tumours showed TLIs of less than 3.0% and these values correlate with their less aggressive clinical behaviour. Labelling of stromal cells and inflammatory cells varied greatly from tumour to tumour; however, no correlation was found with the TLIs of tumour cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6824569      PMCID: PMC2011269          DOI: 10.1038/bjc.1983.32

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  20 in total

1.  Cell cycle parameters in human solid tumors.

Authors:  M J Straus; R E Moran
Journal:  Cancer       Date:  1977-10       Impact factor: 6.860

2.  In vitro measurements of human tumor growth.

Authors:  H Coons; A Norman; A M Nahum
Journal:  Cancer       Date:  1966-09       Impact factor: 6.860

3.  Measurement of DNA synthesis by 3H-thymidine incorporation into needle aspirates from human tumors.

Authors:  B Nordenskjöld; A Zetterberg; T Löwhagen
Journal:  Acta Cytol       Date:  1974 May-Jun       Impact factor: 2.319

4.  In vitro determination of tritiated thymidine labeling index (LI). Evaluation of a method utilizing hyperbaric oxygen and observations on the LI of human mammary carcinoma.

Authors:  J S Meyer; W C Bauer
Journal:  Cancer       Date:  1975-10       Impact factor: 6.860

5.  In vitro uptake of tritiated thymidine by carcinoma of the human colon.

Authors:  L M Lieb; H Lisco
Journal:  Cancer Res       Date:  1966-04       Impact factor: 12.701

6.  In vitro studies of cell proliferation in tumours. I. Critical appraisal of methods and theoretical considerations.

Authors:  G G Steel; J P Bensted
Journal:  Eur J Cancer       Date:  1965-11       Impact factor: 9.162

7.  Cell proliferation and histologic classification of bronchogenic carcinoma.

Authors:  B Hainau; P Dombernowsky; H H Hansen; S Borgeskov
Journal:  J Natl Cancer Inst       Date:  1977-10       Impact factor: 13.506

8.  A rapid in vitro method for measuring cell proliferation in human breast cancer.

Authors:  R J Sklarew; J Hoffman; J Post
Journal:  Cancer       Date:  1977-11       Impact factor: 6.860

9.  Labelling index of human squamous cell carcinomas. Comparison of in vivo and in vitro labelling methods.

Authors:  N Chavaudra; J M Richard; E P Malaise
Journal:  Cell Tissue Kinet       Date:  1979-03

10.  In vitro labeling of solid tissues with tritiated thymidine for autoradiographic detection of S-phase nuclei.

Authors:  J S Meyer; R E Connor
Journal:  Stain Technol       Date:  1977-07
View more
  5 in total

1.  Proliferative and secretory activity in human breast during natural and artificial menstrual cycles.

Authors:  J J Going; T J Anderson; S Battersby; C C MacIntyre
Journal:  Am J Pathol       Date:  1988-01       Impact factor: 4.307

2.  A comparison of patient survival and tumour growth kinetics in human bronchogenic carcinoma.

Authors:  K M Kerr; D Lamb
Journal:  Br J Cancer       Date:  1988-10       Impact factor: 7.640

3.  Cell proliferation, cell loss and expression of bcl-2 and p53 in human pulmonary neoplasms.

Authors:  M M Kennedy; D Lamb; G King; K M Kerr
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

4.  Actual growth rate and tumour cell proliferation in human pulmonary neoplasms.

Authors:  K M Kerr; D Lamb
Journal:  Br J Cancer       Date:  1984-09       Impact factor: 7.640

5.  P53 expression, DNA ploidy and S-phase cell fraction in operable locally advanced non-small-cell lung cancer.

Authors:  A Costa; R Silvestrini; C Mochen; C Lequaglie; P Boracchi; A Faranda; G Vessecchia; G Ravasi
Journal:  Br J Cancer       Date:  1996-04       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.